# Misuse of Drugs (Safe Custody) (Amendment) (Northern Ireland) Regulations 1999

S.R. 1999/252 · made 3 June 1999

These Regulations amend the Misuse of Drugs (Safe Custody) (Northern Ireland) Regulations 1973 in respect of certain products which are used for scientific and diagnostic purposes and which contain an extremely small amount and proportion of controlled drugs. The products in question are exempted from regulations 14 and 18 to 24 of the 1986 Regulations (which relate to documentation, labelling and record keeping) and the security requirements of the 1973 Regulations.

Made under: Misuse of Drugs Act 1971 (Section 7, Section 10, Section 31, Section 38)

## Introductory text

DANGEROUS DRUGS
Made 3rd June 1999
Coming into operation 1st July 1999
The Department of Health and Social Services for Northern Ireland in exercise of the powers conferred by sections 7, 10 and 31 of the Misuse of Drugs Act 1971 as adapted by section 38 of that Act and now vested in it and of every other power enabling it in that behalf and after consultation in accordance with section 31(3) of that Act with the Advisory Council on the Misuse of Drugs, hereby makes the following regulations:—

## 1 Citation and commencement

These Regulations may be cited as the Misuse of Drugs (Safe Custody) (Amendment) (Northern Ireland) Regulations 1999 and shall come into operation on 1st July 1999.

## 2 Interpretation

The Interpretation Act (Northern Ireland) 1954 shall apply to these regulations as it applies to a Measure of the Northern Ireland Assembly.

## 3 Amendment of the Misuse of Drugs (Safe Custody) (Northern Ireland) Regulations 1973

(1) The Misuse of Drugs (Safe Custody) (Northern Ireland) Regulations 1973 shall be amended as follows.
(2) In Schedule 1, after paragraph 3 there shall be added the following paragraph—
“4 Any preparation or other product consisting of one or more component parts, any of which contains a controlled drug, where—
(a) the preparation or other product is not designed for administration of the controlled drug to a human being or animal;
(b) the controlled drug in any component part is packaged in such a form, or in combination with any other active or inert substances in such a manner, that it cannot be recovered by readily applicable means or in a yield which constitutes a risk to health; and
(c) no one component part of the product or preparation contains more than one milligram of the controlled drug or one microgram in the case of lysergide or any other N-alkyl derivative of lysergamide.”

## Signature

Sealed with the Official Seal of the Department of Health and Social Services for Northern Ireland on
L.S.
W. B. Smith
Assistant Secretary
3rd June 1999.

## Explanatory note

(This note is not part of the Regulations.)
These Regulations amend the Misuse of Drugs (Safe Custody) (Northern Ireland) Regulations 1973 in respect of certain products which are used for scientific and diagnostic purposes and which contain an extremely small amount and proportion of controlled drugs. The products in question are exempted from regulations 14 and 18 to 24 of the 1986 Regulations (which relate to documentation, labelling and record keeping) and the security requirements of the 1973 Regulations.

---
Source: https://www.legislation.gov.uk/nisr/1999/252 (the official version)
Page: https://openlegislation.uk/misuse-of-drugs-safe-custody-amendment-northern-ireland-regulations-1999
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.